ASO Visual Abstract: Perioperative Outcomes and Pathological Response After Neoadjuvant Nivolumab Plus Platinum Chemotherapy in Clinically Node-Negative Non-Small Cell Lung Cancer.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

ASO Visual Abstract: Perioperative Outcomes and Pathological Response After Neoadjuvant Nivolumab Plus Platinum Chemotherapy in Clinically Node-Negative Non-Small Cell Lung Cancer. (PubMed, Ann Surg Oncol) - Oct 1, 2026 - No abstract available
Journal • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor

http://www.ncbi.nlm.nih.gov/pubmed/42814253

Hana Oiki; Hironori Tenpaku; Hirotsugu Notsuda; Junichi Soh; Kei Namba; Kentaro Minegishi; Kotaro Nomura; Makoto Endo; Marina Nakatsuka; Masahiro Tsuboi; Masayuki Tanahashi; Mototsugu Shimokawa; Ryuji Nakamura; Satoshi Takamori; Shinkichi Takamori; Shinya Katsumata; Shinya Tane; Shuta Ohara; Takuya Watanabe; Yasuhisa Ohde

Oct 1, 2026